CytoMed Therapeutics Ltd
GDTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873093
In the last 90 days, CytoMed Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 3 institutions reported holding it in 13F filings for Q2 2026, worth $12.2K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding CytoMed Therapeutics Ltd changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 2 | 5 | +3 |
| Shares | 18.1K | 53.1K | +35.0K (+193.1%) |
| Value | $36.1K | $70.8K | +$34.7K (+96.2%) |
New holders (4)
Institutions that held CytoMed Therapeutics Ltd at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 29,829 | $39.7K | 0.00% |
| Two Sigma Securities, LLC | 11,857 | $15.8K | 0.00% |
| StoneX Group Inc. | 10,356 | $13.8K | 0.00% |
| Advisor Group Holdings, Inc. | 21 | $28 | 0.00% |
Sold out (1)
Institutions that held CytoMed Therapeutics Ltd at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Wealthspire Advisors, LLC | 4,835 | $9.62K |